This company is no longer active
Zosano Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$13.53m |
Equity | US$14.05m |
Total liabilities | US$12.39m |
Total assets | US$26.45m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0ZP's short term assets ($15.6M) exceed its short term liabilities ($9.7M).
Long Term Liabilities: 0ZP's short term assets ($15.6M) exceed its long term liabilities ($2.7M).
Debt to Equity History and Analysis
Debt Level: 0ZP is debt free.
Reducing Debt: 0ZP has no debt compared to 5 years ago when its debt to equity ratio was 39.1%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0ZP has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 0ZP has less than a year of cash runway if free cash flow continues to reduce at historical rates of 7.4% each year